- ALLY FINANCIAL INC : MORGAN STANLEY CUTS TO EQUAL-WEIGHT FROM OVERWEIGHT; CUTS TARGET PRICE TO $43.00 FROM $55.00
- Havila Kystruten says September occupancy rises to 82%
- Update: IonQ to Acquire Elisity in Up to $1.3 Billion Deal
- Swiss Franc: Mixed outlook against Euro around French spread moves – ING
- Strategy increased its holdings by 249 BTC last week, with US dollar reserves dropping to $5.52 billion.
- Egypt's natural gas imports will increase by $4.7 billion in the 2025/26 fiscal year, while petroleum product imports will decrease by $1.2 billion.
- Acorn Energy unit OmniMetrix joins Wireless Infrastructure Association
- Hunt Properties, Empery Digital advance Midwest AI data center investment partnership
- Dot Ai Completes $65 Million Acquisition of Envoy Technologies
- SLM CORP <SLM.O>: MORGAN STANLEY RAISES TARGET PRICE TO $30.00 FROM $28.00
- SLM CORP <SLM.O>: MORGAN STANLEY RAISES TARGET PRICE TO $30.00 FROM $28.00
- EBAY INC <EBAY.O>: MORGAN STANLEY RAISES TARGET PRICE TO $132.00 FROM $127.00
- Redfin: US pending home sales slide to lowest since 2014 as mortgage rates top 7%
- BofA Securities Adjusts Cincinnati Financial Price Target to $193 From $187, Maintains Neutral Rating
- Hoodin wins SEK 150,000 follow-on order from enterprise client for custom AI solution
- Bank of Canada: Policy path steady with cautious inflation stance – TD Securities
- Waskita Karya sukuk rating set at idAAA(sy) by Pefindo, outlook negative
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- BofA Securities Adjusts Piper Sandler Price Target to $75 From $81, Maintains Underperform Rating
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- Broadcom (AVGO.US) CEO: The Next Bottleneck for AI is Not Chips But Capital, Yet Many Investors Act Like Gamblers
- BYRNA TECHNOLOGIES INC <BYRN.O>: B. RILEY CUTS TARGET PRICE TO $11 FROM $12
- Volato Group secures up to $1 billion common stock equity facility with institutional investor
- Broadcom (AVGO.US) CEO: The next bottleneck for AI is not chips but capital, yet many investors act like gamblers
- Palisade Bio reports Phase 1a/1b PALI-2108 data showing rapid improvement in moderate-to-severe ulcerative colitis
- nLIGHT to report Q3 2026 results after markets close, host webcast
- Cityvarasto starts share buyback program of up to 45,000 shares, EUR 500,000
- AeroVironment says Halo_Shield counter-UAS system performs strongly in T-REX 26-3 trials
- Volato Group secures up to $1 billion equity facility under common stock purchase agreement
- Geron to present real-world claims study of imetelstat in lower-risk MDS at Japan hematology meeting
- Sutro Biopharma to present at World ADC Conference
- Moon Equity Holdings acquires defense contractor Shieldcom
- Adient schedules call to review Q4 and full-year fiscal 2026 results
- Mips schedules Q3 results presentation conference call
- Dauch: Iles Most Recently Served as CFO at Standard Motor Products >DCH
- Dauch: Terri Kemp, Previously Senior Vice Pres, Chief of Staff and HR, to Retain Role of Senior Vice Pres, Chief of Staff Until Her Retirement at Yr End >DCH
- Aixtron publishes update to financial calendar
- Castellum to attend 2026 Maxim Group Growth Summit, holds investor one-on-ones
- Oscar Health schedules third-quarter earnings call
- AgEagle names Ivan Stamatovski chief technology officer in new C-suite role
- First Tracks Biotherapeutics Says ANB033 Reduces Gluten-Induced Intestinal Damage in Celiac Disease
- Vicor says USITC opens patent probe into vertical power delivery modules, computing systems
- Stoke Therapeutics completes dosing in first two cohorts of Phase 1 OSPREY trial for STK-002 in optic atrophy
- DeFi Development targets faster SOL treasury accumulation with USD 300 million CHAD at-the-market program
- Mirum says Phase 3 EXPAND trial of Livmarli meets primary endpoint in ultra-rare cholestatic liver diseases
- Victory Capital reports $351.9 billion AUM as of Sept. 30, 2026
- IonQ to acquire zero-trust security firm Elisity in all-stock deal valued up to $1.3 billion
- Insight Molecular Diagnostics to join virtual U.S. Bancorp BTIG Kidney Health Forum KOL discussion
- Steris agrees to buy Xodus Medical for $2.1 billion
- IonQ To Acquire Elisity in an all-Stk Transaction Valued at Up to $1.3B >IONQ
- Kraft Heinz to report third-quarter results, host analyst Q&A session
- Stryker takes preferred equity stake in CMR Surgical for USD 400 million
- Evercore hires Baird’s John Song, Jean Stack as senior managing directors in aerospace, defense banking
- Dauch names Nathan Iles CFO effective Dec. 1, 2026
- Weave goes live with Synchrony’s CareCredit integration for patient financing
- BUZZ—First Tracks shares surge boosted by positive results from clinical trials of celiac disease medication
- loanDepot expands Novaprime Foundation platform across post-closing operations
- Redwire ROSA Wings to Launch Aboard SpaceX Mission to Space Station
- Brightline Interactive to attend Maxim Growth Summit
- Freshworks agrees to buy Torii to expand Freshservice into AI, software spend governance
- Ondas, Palantir form Regna AI to build sovereign mission-focused models
- Veralto schedules Q3 2026 earnings call webcast
- Flexsteel schedules first-quarter 2027 earnings release, investor call
- Freshworks To Extend Freshservice Into AI And Software Spend Governance With Agreement To Acquire Torii >FRSH
- Moon Equity Holdings Announced The Strategic Acquisition Of Shieldcom >MONI
- Dauch Nathan Iles Joins as Senior Vice Pres of Finance With Planned Transition to CFO >DCH
- Strategy Acquires 250 BTC And Repurchases $192 Million Of STRC >MSTR
- ANTERO RESOURCES CORPORATION : RAYMOND JAMES RAISES TARGET PRICE TO $58 FROM $55
- T-MOBILE <TMUS.O>: RAYMOND JAMES RAISES TO OUTPERFORM FROM MARKET PERFORM
- Truist Cuts Price Target on Weyerhaeuser to $24 From $28, Keeps Hold Rating
- Market Chatter: CCC Intelligent Solutions in Advanced Sale Talks With GTCR, Elliott Investment
- HUMANA <HUM.N>: RAYMOND JAMES RAISES TO OUTPERFORM FROM MARKET PERFORM
- BIOMARIN PHARMACEUTICAL INC. <BMRN.O>: RAYMOND JAMES RAISES TO STRONG BUY FROM OUTPERFORM
- Enovix Q3 Preliminary Revenue Rises 38%
- ALIGNMENT HEALTHCARE, INC. : RAYMOND JAMES CUTS TARGET PRICE TO $10 FROM $19
- BofA Securities Adjusts Amgen Price Target to $328 From $317, Maintains Underperform Rating
- BUZZ - Harmony Biosciences CEO DeNardo to retire, COO to succeed; shares fall
- Stellantis plans to launch electric vehicle production in Italy and push at least three models.
- US Equity Futures Mostly Flat Pre-Bell Ahead of Week of Earnings, Economic Data
- Clearmind unit Charging Robotics launches autonomous wireless EV-charging platform for robotaxis, fleets
- Analyst: The market absorbed 220,000 BTC last week, with net outflows from exchanges indicating buyer dominance
- SOL Bulls Face a Challenge as Solana Rally Shows Signs of Exhaustion
- Needham Cuts Price Target on Enovis to $34 From $52, Keeps Buy Rating
- Jiuzi Says Undisclosed Investor Commits at Least $50 Million Strategic Investment
- Euro Tech Holdings Signs 50/50 Joint Venture With Sea Clean in Norway
- US Stock Movement: CCC Intelligent surges on October 12th due to GTCR acquisition, Elliott, and insurance SaaS
- Truist Lowers Price Target on Silgan Holdings to $45 From $52, Keeps Buy Rating
- Australia proposes leverage caps for crypto-settled derivatives
- NervGen Doses First Patient in Late-Stage Study of Potential Spinal Cord Injury Treatment
- BUZZ - Shares of quantum computing company IonQ fall after reports of an agreement to acquire cybersecurity firm Elisity
- Insulet Launches Omnipod Discover Platform Across US
- TRON activates post-quantum signatures as Ethereum targets 2029 overhaul
- Dot Ai completes USD 65 million all-stock acquisition of Envoy Technologies
- ANI Pharmaceuticals Says Phase 4 Trial of Iluvien Meets Endpoints in Chronic NIU-PS
- US Dollar Rises Early Monday; Focus on Inflation, Retail Sales This Week
- Earnings Outlook, Easing Bond Yields Lift European Bourses Midday
- Bristol Myers Squibb Says RayzeBio's Phase 3 Study for RYZ101 Meets Primary Endpoint
- C3.AI, INC. : NORTHLAND CAPITAL RAISES TO OUTPERFORM RATING; RAISES TARGET PRICE TO $16 FROM $10
